Risk factors associated with prognosis of patients with medication-related osteonecrosis of the jaw

被引:0
|
作者
Tadokoro, Yoshiaki [1 ]
Hasegawa, Takumi [1 ,2 ]
Takeda, Daisuke [1 ]
Murakami, Aki [1 ]
Yatagai, Nanae [1 ]
Arimoro, Satomi [1 ]
Iwata, Eiji [1 ]
Saito, Izumi [1 ]
Kusumoto, Junya [1 ]
Akashi, Masaya [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Japan
[2] Kobe Univ, Grad Sch Med, Dept Oraland Maxillofacial Surg, Kobe 6500017, Japan
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2024年 / 46卷 / 02期
关键词
medication-related osteonecrosis of the jaw; osteolysis; prognosis; risk factors; sequestration; BISPHOSPHONATE-RELATED OSTEONECROSIS; MULTIPLE-MYELOMA; CANCER-PATIENTS; POSITION PAPER; MANAGEMENT; DENOSUMAB;
D O I
10.1002/hed.27574
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse effect of antiresorptive and/or antiangiogenic agents. As the treatment application for MRONJ is controversial, we aimed to identify the risk factors for poor prognosis and to help determine appropriate management.Methods: This study included 119 patients. Relevant clinical data were obtained for all the patients. In computed tomography images, osteosclerosis, osteolysis, cortical perforation (buccal or lingual), periosteal reaction, and sequestration were evaluated.Results: Multivariate analyses showed statistically significant associations between poor prognosis in patients with MRONJ and conservative treatment alone (hazard ratio [HR] 1.89), osteolysis (HR 4.67), and the absence of sequestration (HR 5.33).Conclusions: Conservative treatment alone without clear objectives needs to be avoided, and osteolytic change could be the criteria for surgical intervention. As the boundary between the lesion and vital bone is indistinct, we recommend extensive surgery in cases with unpredictable sequestration.
引用
收藏
页码:282 / 290
页数:9
相关论文
共 50 条
  • [41] Medication-Related Osteonecrosis of the Jaw-A Continuing Issue
    Wrobel, Krzysztof
    Sikora, Maciej
    Checinski, Maciej
    Jas, Maria
    Chlubek, Dariusz
    APPLIED SCIENCES-BASEL, 2021, 11 (17):
  • [42] Proposal for a preventive protocol for medication-related osteonecrosis of the jaw
    Romero-Ruiz, Manuel Ma
    Romero-Serrano, Marta
    Serrano-Gonzalez, Ascension
    Angeles Serrera-Figallo, Maria
    Luis Gutierrez-Perez, Jose
    Torres-Lagares, Daniel
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2021, 26 (03): : E314 - E326
  • [43] The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention
    Di Fede, Olga
    Panzarella, Vera
    Mauceri, Rodolfo
    Fusco, Vittorio
    Bedogni, Alberto
    Lo Muzio, Lorenzo
    Sipmo Onj, Board
    Campisi, Giuseppina
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [44] Diabetes as a Risk Factor for Medication-Related Osteonecrosis of the Jaw
    Peer, A.
    Khamaisi, M.
    JOURNAL OF DENTAL RESEARCH, 2015, 94 (02) : 252 - 260
  • [45] Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases
    Otto, Sven
    Pautke, Christoph
    Van den Wyngaert, Tim
    Niepel, Daniela
    Schiodt, Morten
    CANCER TREATMENT REVIEWS, 2018, 69 : 177 - 187
  • [46] Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer
    Sim, Ie-Wen
    Sanders, Kerrie M.
    Borromeo, Gelsomina L.
    Seymour, John F.
    Ebeling, Peter R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (10) : 3887 - 3893
  • [47] Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series
    Rugani, Petra
    Acham, Stephan
    Kirnbauer, Barbara
    Truschnegg, Astrid
    Obermayer-Pietsch, Barbara
    Jakse, Norbert
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (06) : 1329 - 1338
  • [48] CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw
    Baba, Akira
    Goto, Tazuko K.
    Ojiri, Hiroya
    Takagiwa, Mutsumi
    Hiraga, Chiho
    Okamura, Masahiro
    Hasegawa, Sho
    Okuyama, Yumi
    Ogino, Nobuhiro
    Yamauchi, Hideomi
    Kobashi, Yuko
    Yamazoe, Shinji
    Munetomo, Yohei
    Mogami, Takuji
    Nomura, Takeshi
    DENTOMAXILLOFACIAL RADIOLOGY, 2018, 47 (04)
  • [49] Interventions for managing medication-related osteonecrosis of the jaw
    Beth-Tasdogan, Natalie H.
    Mayer, Benjamin
    Hussein, Heba
    Zolk, Oliver
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [50] Bacterial diversity in medication-related osteonecrosis of the jaw
    Hallmer, Fredrik
    Bjornland, Tore
    Andersson, Gunilla
    Becktor, Jonas P.
    Kristoffersen, Anne K.
    Enersen, Morten
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2017, 123 (04): : 436 - 444